REVIEW ARTICLES

[Note: Volume 26, Issue 6 is indexed in Current Awareness in Biological Sciences (BIO-BASE) & Embase/Excerpta Medica only)

MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition
Grigorios Theodoropoulos, Evangelos Tsiambas, Paraskevi Tziakou, Despoina Spyropoulou, Athanasios Niotis, Harikleia Gakiopoulou, Odysseas Dimas, Loukas Manaios, Andreas C Lazaris, Georgia Thomopoulou; pp 2209-2212 (PDF)

Induction chemotherapy in head and neck cancers – old actors, new horizons
Camil Ciprian Mirestean, Roxana Irina Iancu, Dragos Teodor Petru Iancu; pp 2213-2217 (PDF)

Caspases –related apoptosis in meningiomas 
Dimitrios Roukas, Stylianos Mastronikolis, Evangelos Tsiambas, Despoina Spyropoulou, Ioannis Stavrakis, Vasileios Ragos, Pavlos Pantos, Anastasios Kouzoupis, Nikolaos Kavantzas, Andreas Lazaris; pp 2218-2221 (PDF)

[Retracted] Surgical management in hepatocellular carcinoma with portal vein tumor thrombosis: Is this the end of the road or a chance to expand the criteria for resectability?
Nikolaos Benetatos, Iliana Papadopoulou, Stelios F. Assimakopoulos, Evangelos Iliopoulos, Stylianos Germanos, Michail Vailas, Maria Sotiropoulou, Panagiotis Kitrou, Konstantinos Katsanos, Christina Kalogeropoulou, Ioannis Maroulis; pp 2222-2230 (PDF)

(This article has been retracted. See the Retraction notice here)

Chromosomal instability landscape in uveal melanoma
Stylianos Mastronikolis, Maria Adamopoulou, Dimitrios Roukas, Sofianiki Mastronikoli, Panagiotis Fotiades, Evangelos Tsiambas, Constantin Georgakopoulos; pp 2231-2233 (PDF)

Biomarkers and common oral cancers: Clinical trial studies
Emran Hajmohammadi, Saina Ghahremanie, Mostafa Alam, Kamyar Abbasi, Fatemeh Mohamadian, Danial Khayatan, Hamid Tebyaniyan, Mahdi Rahbar; pp 2234-2244 (PDF)

Orbital lymphomas in autoimmune diseases
Vasileios Ragos^, Stylianos Mastronikolis, Christoforos Asproudis, Ioannis Stavrakis, Anna Batistatou, Despoina Spyropoulou, Panagiotis Fotiades, Dimitrios Peschos, Ioannis Asproudis, Maria Adamopoulou, Evangelos Tsiambas, Nicholas Mastronikolis; pp 2245-2247 (PDF)

ORIGINAL ARTICLES

BREAST CANCER

[Retracted] Correlation between ultrasound-guided staining margin and survival rate, recurrence rate and cosmetic effect of breast cancer patients
Liyuan Ma, Haigen Xi, Guangfei Yang, Qianfeng Ma, Bo Wu, Tao Jiang; pp 2248-2254 (PDF)

(This article has been retracted. See the Retraction notice here)

The prevalence and prognostic importance of the androgen receptor in triple-negative breast cancer
Elif Sila Erim, Gurdeniz Serin, Ulus Ali Sanli, Erhan Gokmen, Osman Zekioglu, Burcu Cakar; pp 2255-2261 (PDF)

Risk reducing mastectomy in patients with and without gene mutation: experience in an Italian Breast Unit
Daniele La Forgia, Sergio Diotaiuti, Rossana Altieri, Nicola Cortese, Maria Digennaro, Annarita Fanizzi, Margherita Patruno, Raffaella Massafra, Angelo Virgilio Paradiso; pp 2262-2267 (PDF)

Fibroblast growth factor-23 in HER2 positive breast cancer: its expression and correlation with adjuvant EC->D+T treatment induced cardiotoxicity risk
Qian Zhang, Dengfeng Chen; pp 2268-2275 (PDF)

Correlation between clinicopathologic factors and recurrence score according to TAILOR x risk category in patients with hormone receptor positive early-stage breast cancer
Kezban Nur Pilanci, Caglar Unal, Cetin Ordu, Erhan Gokmen, Mustafa Ozdogan, Nilufer Guler, Cihan Uras, Orhan Demircan, Abdurrahman Isikdogan, Halil Kara, Abdullah Bahadir Oz, Gul Alco, Pinar Saip,Yesim Eralp, Vahit Ozmen; pp 2276-2283 (PDF)

A new predictive marker for predicting response after neoadjuvant chemotherapy in hormone receptor positive/HER2-negative patients: a logarithmic model
Yakup Iriagac, Eyyup Cavdar, Kubilay Karaboyun, Seher Yildiz Tacar, Halil Taskaynatan, Okan Avci, Ahmet Yolcu, Sibel Ozkan Gurdal, Meltem Oznur, Erdogan Selcuk Seber; pp 2284-2291 (PDF)

Clinical and histopathological characteristics of male breast cancer: A single center experience
Gulnihan Kupik, Osman Kupik, Kadri Altundag; pp 2292-2297 (PDF)

The effect of boost radiotherapy on local control in ductal carcinoma in-situ of the breast: Retrospective single-center experience with literature review
Ahmet Serkan Ilgun, Gul Alco, Alper Ozturk, Filiz Celebi, Zeynep Erdogan, Cetin Ordu, Fatma Aktepe, Gursel Soybir, Vahit Ozmen; pp 2298-2305 (PDF)

The contributory role of multidisciplinary meetings in the diagnosis and treatment of breast cancer
Binnur Donmez Yilmaz, Semra Gunay, Asli Erturk, Aysun Arslantas, Pinar Ozay Nayir, Sevda Saglampinar Karyagar, Biray Erturk, Sener Cihan; pp 2306-2311 (PDF)

miR-301a-5p negatively affects Treg and Th17 related gene expression in contrast to miR-21 and miR-23b-5p in early-stage breast tumor tissue
Lyuba Miteva, Stoyan Nikolov, Noyko Stanilov, Petio Chilingirov, Spaska Stanilova; pp 2312-2320 (PDF)

GYNECOLOGIC CANCERS

Supportive care needs, psychological distress and social support of patients with gynecologic cancer before surgery
Konstantina Menti, Ourania Govina, Eleni Dokoutsidou, Theocharis Konstantinidis, Andreas Charalambous, Theodoula Adamakidou; pp 2321-2329 (PDF)

Efficacy of transumbilical laparoendoscopic single-site staging surgery in treating endometrial cancer
Yanyan Dou, Xiangmei Zheng; pp 2330-2336 (PDF)

Ovarian cystectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy: a randomized controlled trial
Jing Li, Manzhu He, Tao Hou; pp 2337-2344 (PDF)

CircMUC16 activates AKT3 pathway to promote the malignant progression of cervical cancer
Qinwei Zhang, Fang Zhang, Yaner Dong, Youchun Ye, Zhongna Yu; pp 2345-2352 (PDF)

Fucoidan inhibits ovarian cancer growth via the miR-20a-5p/PKD2 axis
Ziqi Cheng, Yapei Lu, Yuan Fang; pp 2353-2359 (PDF)

Lidocaine for ovarian cancer. Preclinical in vitro data
Razvan Popa, Diana Cenariu, Ancuta Jurj, Noemi Dirzu, Sergiu Pasca, Tiberiu Tat, Daniela Ionescu, Alexandru Irimie; pp 2360-2367 (PDF)

CUL4B/KLF11 axis promotes malignant ovarian cancer progression
Yapei Lu, Ziqi Cheng; pp 2368-2374 (PDF)

The best evidence for the prevention and management of lower extremity deep venous thrombosis after gynecological malignant tumor surgery: A systematic review and network meta-analysis
Jiaqi Hu, Yidan Geng, Jingyi Ma, Xuefan Dong, Shuqin Fang, Jianli Tian; pp 2375-2382 (PDF)

LIVER CANCERS

MiR-378a-3p represses malignant behaviors in liver hepatocellular carcinoma via targeting SIRT6
Geqiong Xiao, Hui Liao, Mengyu Ding, Qiong Wang, Wenwen Zhu, Jian Chang, Liang Wang; pp 2383-2394 (PDF)

LncRNA00978 contributes to cells growth and metastasis in hepatocellular carcinoma via mediating miR-125b-5p/SOX12 pathway
Zhiqing Cheng, Limei Gong, Shan Lin, Xiaojie Jiang, Qinghe Cai; pp 2395-2404 (PDF)

[Retracted] CircFMN2 boosts sorafenib resistance in hepatocellular carcinoma cells via up-regulating CNBP by restraining ubiquitination
Chen Fan, Xiaoli Zhu, Qi Zhou, Weidong Wang; pp 2405-2413 (PDF)

(This article has been retracted. See the Retraction notice here)

PCGEM1 triggers liver cancer progression by positively regulating SNAI1
Yong Wang, Chen Chen, Xintian Wang, Chao Jiang; pp 2414-2420 (PDF)

Non-alcoholic fatty liver disease and extra-hepatic malignancies
Tudor Cuciureanu, Carol Stanciu, Sebastian Zenovia, Cristina M. Muzica, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Catalin Sfarti, Vladut Mirel Burduloi, Anca Trifan; pp 2421-2425 (PDF)

COLORECTAL CANCERS

Outcomes of laparoscopic complete mesocolic excision for transverse colon cancer in elderly patients
Jianhua Dong, Xianshuo Cheng, Ming Li, Kun Yu; pp 2425-2432 (PDF)

Capecitabine combined with bevacizumab in maintenance therapy of metastatic colorectal cancer: a retrospective clinical study
Jianhua Zhu, Wei Xu, Wei Tang; pp 2433-2439 (PDF)

PLA2G3 phospholipase expression patterns in colon adenocarcinoma
Evangelos Falidas, Eirini Kitsiouli, Dimitrios Tsounis, Asimina Kalogirou, Evangelos Tsiambas, Paraskevi Tziakou, George Tsouvelas, Stylianos Papadopoulos, Michail Mitsis, Marilena Lekka, Despoina Spyropoulou, Konstantinos Vlachos; pp 2440-2444 (PDF)

GASTRIC CANCERS

Super enhancer-associated CCAT1 lncRNA promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in gastric cancer
Lingzhi Peng, Tianxiang Liu, Chenglou Zhu, Chongya Yang, Qiong Wang, Mingxu Da; pp 2445-2454 (PDF)

Analysis on safety and efficacy of low-dose apatinib combined with paclitaxel as second-line treatment for advanced gastric cancer
Yang Xue-Jing, Song Dong, Yang Xiao-Ling, Guo Xin; pp 2455-2461 (PDF)

Association between high initial CEA, CA 19-9 levels and HER-2 status and their prognostic values on overall survival in metastatic gastric cancer
Fatih Selcukbiricik, Kayhan Erturk, Emre Balık, Buket Bayram Kuvvet, Melisa Celayir, Farid Babashov, Deniz Tural, Begum Guler Sentürk, Nil Molinas Mandel; pp 2462-2466 (PDF)

LUNG CANCERS

Comparison of response and survival of first-line crizotinib therapy according to EML-4 ALK fusion variants in advanced non-small cell lung cancer patients: A Turkish Oncology Group study
Ali Murat Tatli, Perran Fulden Yumuk, Buge Oz, Ahmet Bilici, Pınar Gursoy, Erdem Goker, Ahmet Sezer, Ahmet Ozet, Umut Demirci, Emine Bozkurtlar, Irem Hicran Ozbudak, Deniz Nart, Tugba Canpolat, Nalan Akyurek, Saadettin Kilickap; pp 2467-2474 (PDF)

[Retracted] NTF4 promoted the malignant progression of NSCLC by negatively regulating FOXL1
Lin Mu, Hong Zhao, Yifeng Zhang, Chun Xiao; pp 2475-2479 (PDF)

(This article has been retracted. See the Retraction notice here)

Clinical analysis of anlotinib in the third-line treatment of advanced non-small cell lung cancer
Wenrui Jiang, Xing Tang, Yuan Fang, Shuo Wu, Fang Yang; pp 2480-2486 (PDF)

PANCREATIC CANCERS

Efficacy of modified FOLFIRINOX neoadjuvant chemotherapy combined with surgery on resectable pancreatic cancer
Xiang Feng, Yuyao Liu, Tiantian Zhao, Yawen Gao; pp 2487-2493 (PDF)

Prognostic factors and prognostic index for patients with advanced pancreatic cancer
Single center experience and review of the literature
Ilkay Tugba Unek, Tarkan Unek, Dogan Koca, Tulay Akman, Tarik Salman, Hulya Ellidokuz, Olcun Umit Unal, Ilhan Oztop, Funda Obuz, Ugur Yilmaz; pp 2494-2505 (PDF)

Combination of gemcitabine, infusional 5-fluorouracil and high-dose folinic acid (GEMFUFOL) as adjuvant chemotherapy in resected pancreatic cancer
Ilkay Tugba Unek, Ilhan Oztop, Dogan Koca, Tarkan Unek, Anil Aysal Agalar, Zeynep Gulsum Guc, Sinan Unal, Zumre Arican Alicikus, Asim Leblebici, Hulya Ellidokuz, Ozgul Sagol, Ugur Yilmaz; pp 2506-2514 (PDF)

CNS TUMORS

Clinical application of patient derived xenograft mouse model in children with neuroblastoma
Keke Chen, Zhijun Huang, Xianbo Shen, Xin Tian, Chengguang Zhu, Qin Shi, Minhui Zen, Zexi Yin, Xiangling He; pp 2515-2524 (PDF)

Vitamin C through upregulating SYNPO2 level suppresses the proliferation and migration of glioma cells
Yishuo Zhu, Xuan Wang, Yujie Cui, Jin Bai, Junnian Zheng, Yuechao Fan; pp 2525-2530 (PDF)

GERM CELL TUMORS

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with relapsed or refractory germ cell tumors
Jale Yildiz, Bahar Uncu Ulu, Tugce Nur Yigenoglu, Semih Basci, Mehmet Bakirtas, Derya Sahin, Tahir Darcin, Hikmetullah Batgi, Nuran Ahu Baysal, Dicle Iskender, Alparslan Merdin, Merih Kizil Cakar, Mehmet Sinan Dal, Fevzi Altuntas; pp 2531-2536 (PDF)

HEMATOLOGIC MALIGNANCIES

Pathomorphological and clinical features of diffuse large B-cell lymphoma in Southeastern Serbia – seven-year experience at a tertiary center
Miljan S. Krstic, Slavica M. Stojnev, Ivan Z. Petkovic, Irena K.Conic, Janko T. Zujovic, Velimir S. Milosevic; pp 2546-2553 (PDF)

Galectins in acute myeloid leukemia: gene expression profiling with clinical emphasis
Mahmoud M. Abdelfattah, Magda M. Assem, Asmaa A. El Leithy, Rasha Mahmoud Allam, Naglaa M. Hassan, Reham Helwa; pp 2554-2562 (PDF)

PROSTATE CANCER

LncARSR promotes prostate cancer proliferation by activating PTEN/PI3K/Akt pathway
Gang Liu, Jingjun Zhang, Mingyong Liu, Zhiqiang Sun, Hanwen Cui; pp 2563-2568 (PDF)

Significance of prostate health index and its density to predict aggressive prostate cancer at final pathology
Marija Barisiene, Arnas Bakavicius, Diana Stanciute, Jolita Jurkeviciene, Arunas Zelvys, Albertas Ulys, Dalius Vitkus and Feliksas Jankevicius; pp 2569-2575 (PDF)

RENAL CELL CARCINOMAS

PD-L1 protein expression patterns in renal cell carcinoma based on conventional and digitized evaluation
Paraskevi Tziakou, Grigorios Theodoropoulos, Evangelos Tsiambas, Gerasimos Kollaitis, Eirini Thymara, Nikolaos Kavantzas, Andreas C. Lazaris; pp 2576-2580 (PDF)

First-line pazopanib in metastatic renal cell carcinoma: Multicenter experience
Oyman Abdilkerim, Ozcelik Melike, Basak Mustafa, Gokyer Ali, Mahmut Emre Yildirim; pp 2581-2586 (Pubmed Abstract, PDF)

BLADDER CANCER

Assessment of ex-vivo efficacy of immunotherapeutic agents in intermediate-risk and high-risk non-muscle invasive bladder cancer
Serdar Celik, Aylin Erol, Ozde Gokbayrak, Hilmi Sari, Batuhan Yilmaz, Mehmet Ugur Mungan, Kutsal Yorukoglu, Guven Aslan, Ilhan Celebi, Zekiye Altun, Tugba Yavuzsen, Safiye Aktas; pp 2587-2594 (PDF)

ESOPHAGEAL CANCER

Hypoxia signature associated with tumor immune microenvironment in the esophageal squamous cell carcinoma
Wujun Zheng; pp 2595-2603 (PDF)

HEAD & NECK CANCER

Different influences of risk factors on the development of head and neck tumors and other oncological diagnoses
Lickova Katerina, Ambrus Miloslav, Klezl Petr, Vranova Jana, Kratka Zuzana, Cocek Ales; pp 2604-2613 (PDF)

MELANOMA

[Retracted] MiR-22 alleviates the proliferation and metastasis of melanoma by targeting FASN
Jun Qiu, Yanhua Yi, Yong Miao, Zhiqi Hu; pp 2614-2619 (PDF)

(This article has been retracted. See the Retraction notice here)

ORAL CANCER

[Retracted] c-Jun alterations in oral squamous cell carcinoma
Nicholas Mastronikolis, Evangelos Tsiambas, Panagiotis P Fotiades, Efthymios Kyrodimos, Aristeidis Chrysovergis, Vasileios Papanikolaou, Dimitrios Roukas, Asimakis Asimakopoulos, Sofianiki Mastronikoli, Vasileios Ragos; pp 2620-2622 (PDF)

(This article has been retracted. See the Retraction notice here)

RETINOBLASTOMA

[Retracted] Effects of long non-coding RNA MALAT1 targeting miR-570-3p and miR-34a on invasion, proliferation and apoptosis of human retinoblastoma cells
Dejing Shi, Xiuhong Feng, Xuchen Ding; pp 2623-2630 (PDF)

(This article has been retracted. See the Retraction notice here)

THYROID CANCER

Radioactive iodine treatment planning for differentiated thyroid carcinoma: Comparison of different machine learning classification models
Marina Popovic, Dragana Sobic Saranovic, Milos Nikolic, Dusan Teodorovic, Ivan Markovic, Ljiljana Mijatovic Teodorovic; pp 2631-2638 (PDF)

URINARY CANCER

The prognostic impact of ABO blood groups and Rhesus factor in patients with upper tract urothelial carcinoma
Djordje Radisavcevic, Zoran Dzamic, Emre Cico, Sandra Sipetic Grujicic, Bogomir Milojevic; pp 2639-2644 (PDF)

MISCELLANEOUS

A new protocol of desensitization for systemic therapy agents in oncology
Calin Cainap, Sanziana Cetean, Andrei Havasi, Ovidiu Crisan, Ovidiu Balacescu, Laura Ancuta Pop, Loredana Balacescu, Andra Piciu, Alexandru Mester, Doina Piciu, Adina Stan, Alina Bereanu, Catalin Vlad, Patriciu Achimas, Simona Cainap; pp 2645-2652 (PDF)

Functional neuroctomy in tumor-related and idiopathic trigeminal neuralgia
Vasileios Ragos, Asimakis Asimakopoulos, Evangelos Tsiambas, George Papanastasiou, George Argyris, Athanasios Niotis, Panagiotis Fotiades, George Psychogios; pp 2653-2657 (PDF)

Cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC) in the treatment of primary and metastatic pleural malignancies – is extension of indications possible?
Dejan Stojiljkovic, Nada Santrac, Dijana Mircic, Dusan Ristic, Tanja Stojiljkovic, Ana Cvetkovic; pp 2658-2663 (PDF)

[Retracted] Breast, ovarian and other site cancer patients with BRCA 1/2 mutations: Data from Turkish multicenter retrospective study
Osman Kostek, Ahmet Kucukarda, Hilmi Tozkir, Ilker Nihat Okten, Ercan Ozden, Devrim Cabuk, Murat Sari, Emre Cakir, Ilhan Hacibekiroglu, Mustafa Gurbuz, Yuksel Urun, Bahiddin Yilmaz, Cihan Erol, Mehmet Ali Nahit Sendur, Emrah Eraslan, Umut Demirci, Zeynep Oruc, Mehmet Ali Kaplan, Ali Gokyer, Ivo Gokmen, Erkan Ozcan, Muhammet Bekir Hacioglu, Bulent Erdogan, Selma Demir, Sernaz Uzunoglu, Mahmut Gumus, Hakan Gurkan, Irfan Cicin; pp 2664-2671 (PDF)

(This article has been retracted. See the Retraction notice here)

Corrected QT prolongation among chemotherapy – treated patients: A study of a Romanian center
Cristina Crisan, Calin Cainap, Anca Farcas, Tiberiu Moldovan, Eduard Radu, Ovidiu Bochis, Gabriela Morar-Bolba, Adina Stan, Alina Bereanu, Catalin Vlad, Patriciu Achimas, Simona Căinap; pp 2672-2677 (PDF)

Chemotherapy in cholangiocarcinoma – experience of a tertiary cancer center from Romania
Catalin Vlad, Andrei Havasi, Patriciu Achimas, Calin Cainap, Laura Pop, Daniel Sur, Andra Piciu, Andra Stan, Alina Bereanu, Florina Gabor-Harosa, Iulia Zehan, Ana Teodora Havasi, Simone Cainap; pp 2678-2687 (PDF)

Inmate cancer patient – Highlighting the importance of a holistic approach to oncological care
Maria Tolia, Emmanouil K.Symvoulakis, Konstantinos Kamposioras, Davide Mauri, Angeliki Skoutari, Panagiotis Volkos, Dimitrios Schizas, Athanasios Spanos, Ioannis Kokakis, Nikolaos Tsoukalas, Nikolaos Charalampakis, Francesco Cuccia, Filippo Alongi, Ramon Andrade de Mello, Katerina M Antoniou, Thomas Hyphantis, Ioanna Nixon, Dimitris Matthaios, Michail Nikolaou, Francesco de Lorenzo, Kathi Apostolidis; pp 2688-2703 (PDF)

LETTERS TO THE EDITOR

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: is it too early to reach conclusion?
Ahmet N.Sanli, Kadri Altundag; p 2704 (PDF)

Regular daily weighted Hula-Hooping might reduce central adiposity leading to decreased pre- and postmenopausal breast cancers risk
Ahmet N.Sanli, Kadri Altundag; p 2705 (PDF)

SARS-CoV-2 implication in retinoblastoma
Claire Konstantopoulou, Dimitrios Roukas, Paraskevi Tziakou, Evangelos Tsiambas; p 2706 (PDF)

Synchronous breast cancer metastases both to parotid and thyroid glands: a rare presentation
Ahmet N.Sanli, Kadri Altundag; p 2707 (PDF)

P53/MDM-2 gene alterations in laryngeal squamous cell carcinoma
Vasileios Papanikolaou, Efthymios Kyrodimos, Evangelos Tsiambas, Aristeidis Chrysovergis; p 2708 (PDF)

Solitary radius metastasis in a breast cancer patient: a rare presentation
Ahmet N.Sanli, Kadri Altundag; p 2708 (PDF)

Triple negative apocrine breast cancer with atypical metastatic presentations
Kadri Altundag; p 2709 (PDF)

Microsatellite instability in oral squamous cell carcinoma
Efthymios Kyrodimos, Aristeidis Chrysovergis, Evangelos Tsiambas, Vasileios S.Papanikolaou; p 2709 (PDF)

Isolated contralateral axillary lymph node recurrence in breast cancer
Kadri Altundag; pp 2710-2711 (PDF)

RETRACTIONS

Retraction Note to: Inhibition of cancer cell growth in cisplatin-resistant human oral cancer cells by withaferin-A is mediated via both apoptosis and autophagic cell death, endogenous ROS production, G2/M phase cell cycle arrest and by targeting MAPK/RAS/RAF signalling pathway
Xuelian Yin, Guang Yang, Dongjie Ma, Zhejun Su; p 2712 (PDF)

Retraction Note to: Amarogentin secoiridoid inhibits in vivo cancer cell growth in xenograft mice model and induces apoptosis in human gastric cancer cells (SNU-16) through the mediation of G2/M cell cycle arrest and PI3K/Akt signalling pathway
Jian-guo Zhao, Ling Zhang, Xiao-jun Xiang, Feng Yu,Wan-li Ye, Dong-ping Wu, Jian-fang Wang, Jian-ping Xiong; p 2713 (PDF)

Retraction Note to: Kutkoside-an iridoid glycoside, exerts anti-proliferative effects in drug-resistant human oral carcinoma cells by targeting PI3K/AKT signalling pathway, inducing apoptosis and suppressing cell migration and invasion
Jun-Chi Hou, Xiao-Nan Xu; p 2714 (PDF)

Retraction Note to: Heptazoline exerts antiproliferative effects on human melanoma cells by inducing apoptosis, cell cycle arrest and targeting MAPK signalling pathway
Wei Zhou，Ling Zhou，Min Wang，Zeming Liu，Danyang Chen，Liang Guo; p 2715 (PDF)

Retraction Note to: Anticancer effects of juglone in OVCAR-3 human ovarian carcinoma are facilitated through programmed cell death, endogenous ROS production, inhibition of cell migration and invasion and cell cycle arrest
Jun-Yu Shi, Zhe-Ren Huang, Hong-Yan Gao, Xiao-Li Xu; p 2716 (PDF)

Retraction Note to: Gammacerane suppresses the growth of human endometrial carcinoma cells via induction of apoptosis, cell cycle arrest, inhibition of cell migration, invasion and STAT3 signaling pathway
Chenming Wang, Shaozheng Chen, Xiuying Yue; p 2717 (PDF)

Retraction Note to: LncRNA SBF2-AS1 inhibits apoptosis and promotes proliferation in lung cancer cell via regulating FOXM1
Haiyan Qi, Luozhen Wang, Xiaomei Zhang, Wei Sun, Jingqin Liu; p 2718 (PDF)

Retraction Note to: Berberine inhibits human gastric cancer cell growth via deactivation of p38/JNK pathway, induction of mitochondrial-mediated apoptosis, caspase activation and NF-κB inhibition 
Yue Wang, Mingyin Zhou, Dong Shang; p 2719 (PDF)

Retraction Note to: Angustifoline inhibits human colon cancer cell growth by inducing autophagy along with mitochondrial-mediated apoptosis, suppression of cell invasion and migration and stimulating G2/M cell cycle arrest
Zheyu Ding, Qingbo Chen, Bin Xiong, Yingli Cun , Hongbo Wang, Mingyao Xu; p 2720 (PDF)

Retraction Note to: In vitro and in vivo antitumor activity of neochlorogenic acid in human gastric carcinoma cells are complemented with ROS generation, loss of mitochondrial membrane potential and apoptosis induction
Wei Fang, Yuntao Ma, Juan Wang, Xiaojun Yang, Yuanhui Gu, Yiping Li; p 2721 (PDF)

Retraction Note to: Taxifolin inhibits the development of scar cell carcinoma by inducing apoptosis, cell cycle arrest, and suppression of PI3K/AKT/mTOR pathway 
Wei Zhou, Zeming Liu, Min Wang, Danyang Chen, Ling Zhou, Liang Guo; p 2722 (PDF),

Retraction Note to: Piperine alkaloid induces anticancer and apoptotic effects in human breast carcinoma cells mediated via cell migration and cell invasion inhibition, G2/M phase cell cycle arrest and targeting PI3K/AKT signaling pathway

Min Qiu, Chunyan Xue, Lingyan Zhang; p 2723 (PDF)

Retraction Note to: MicroRNA-24 regulates the growth and chemosensitivity of the human colorectal cancer cells by targeting RNA-binding protein DND1 
Qiuhuan Zhang, Wenjing Li, Gang Liu, Weizhong Tang; p 2724 (PDF)

Retraction Note to: Synergistic enhancement of the antitumor activity of 5-fluorouracil by bornyl acetate in SGC-7901 human gastric cancer cells and the determination of the underlying mechanism of action
Juan Li, Shao-Xuan Wang; p 2725 (PDF)

Retraction Note to: Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis and promotes cell proliferation, invasion and migration
Yan Zhang, Tao Wang, Hua-Qiao Huang, Wei Li, Xiao-Ling Cheng, Jing Yang; p 2726 (PDF)